Total: £ 56.28
Published Date: 2026-05-15 | Pages: 114 | Tables: 108 | Pharma & Healthcare
The global Budesonide and Formoterol Fumarate market was valued at US$ 2500 million in 2025 and is anticipated to reach US$ 4007 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Budesonide and Formoterol Fumarate competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Budesonide and Formoterol Fumarate is a compound inhalation preparation consisting of budesonide, an inhaled corticosteroid, and formoterol, a long-acting β₂-adrenergic agonist. It exerts both anti-inflammatory and bronchodilator effects: budesonide reduces airway inflammation and hyperresponsiveness, while formoterol relaxes bronchial smooth muscle rapidly. It is mainly used for the long-term management and maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), effectively relieving wheezing and dyspnea, and reducing the risk of acute exacerbations.In 2025, global Budesonide and Formoterol Fumarate production reached approximately 320 million units
Budesonide and formoterol is a core fixed-dose combination inhaled therapy for the global management of asthma and chronic obstructive pulmonary disease (COPD). With its dual mechanism of anti-inflammatory action and bronchodilation, it has long maintained a first-line clinical position. Historically dominated by originator brands, the global market has gradually diversified as patents expired and generic versions entered the market. Domestic and international generics have rapidly gained penetration through cost-effective advantages, driving higher overall market accessibility. On the demand side, rising global prevalence of chronic respiratory diseases, improved standardization of diagnosis and treatment, the implementation of tiered healthcare and chronic disease management policies, as well as consistent guideline recommendations for this combination therapy, collectively support steady market growth. At the same time, the sector faces challenges including intensified generic competition, pricing pressure, and patient share diversion from novel triple combinations and biological therapies. Overall, thanks to its well-established efficacy and broad indications, the product will continue to see stable market demand, with competition increasingly focusing on product quality, inhaler device optimization, cost control, and expansion in primary care and overseas markets.
This report delivers a comprehensive overview of the global Budesonide and Formoterol Fumarate market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Budesonide and Formoterol Fumarate. The Budesonide and Formoterol Fumarate market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Budesonide and Formoterol Fumarate market comprehensively. Regional market sizes by Type, by Application, by Dosage Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Budesonide and Formoterol Fumarate manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AstraZeneca
Viatris
Teva
Sandoz
Chia Tai Tianqing Pharmaceutical
Joincare Pharmaceutical Group Industry
Lunan Pharmaceutical Group
Segment by Type
80/4.5 μg / inhalation
160/4.5 μg / inhalation
Segment by Dosage Form
Inhalation Powder
Inhalation Aerosol
Segment by Production Technology
Innovator
Generic
Segment by Sales Channels
Hospitals
Retail
Online
by Application
Asthma
Chronic Obstructive Pulmonary Disease
Airway Constriction Relief
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Budesonide and Formoterol Fumarate manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Budesonide and Formoterol Fumarate sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Budesonide and Formoterol Fumarate Market Overview
1.1 Product Definition
1.2 Budesonide and Formoterol Fumarate by Type
1.2.1 Global Budesonide and Formoterol Fumarate Market Value by Type: 2025 vs 2032
1.2.2 80/4.5 μg / inhalation
1.2.3 160/4.5 μg / inhalation
1.3 Budesonide and Formoterol Fumarate by Dosage Form
1.3.1 Global Budesonide and Formoterol Fumarate Market Value by Dosage Form: 2025 vs 2032
1.3.2 Inhalation Powder
1.3.3 Inhalation Aerosol
1.4 Budesonide and Formoterol Fumarate by Production Technology
1.4.1 Global Budesonide and Formoterol Fumarate Market Value by Production Technology: 2025 vs 2032
1.4.2 Innovator
1.4.3 Generic
1.5 Budesonide and Formoterol Fumarate by Sales Channels
1.5.1 Global Budesonide and Formoterol Fumarate Market Value by Sales Channels: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Retail
1.5.4 Online
1.6 Budesonide and Formoterol Fumarate by Application
1.6.1 Global Budesonide and Formoterol Fumarate Market Value by Application: 2025 vs 2032
1.6.2 Asthma
1.6.3 Chronic Obstructive Pulmonary Disease
1.6.4 Airway Constriction Relief
1.6.5 Others
1.7 Global Budesonide and Formoterol Fumarate Market Size Estimates and Forecasts
1.7.1 Global Budesonide and Formoterol Fumarate Revenue 2021–2032
1.7.2 Global Budesonide and Formoterol Fumarate Sales 2021–2032
1.7.3 Global Budesonide and Formoterol Fumarate Market Average Price (2021–2032)
1.8 Assumptions and Limitations
2 Budesonide and Formoterol Fumarate Market Competition by Manufacturers
2.1 Global Budesonide and Formoterol Fumarate Sales Market Share by Manufacturers (2021–2026)
2.2 Global Budesonide and Formoterol Fumarate Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Budesonide and Formoterol Fumarate Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Budesonide and Formoterol Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Product Types and Applications
2.7 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Date of Entry into the Industry
2.8 Global Budesonide and Formoterol Fumarate Market Competitive Situation and Trends
2.8.1 Global Budesonide and Formoterol Fumarate Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Budesonide and Formoterol Fumarate Players Market Share by Revenue
2.8.3 Global Budesonide and Formoterol Fumarate Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Budesonide and Formoterol Fumarate Market Scenario by Region
3.1 Global Budesonide and Formoterol Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Budesonide and Formoterol Fumarate Sales by Region: 2021–2032
3.2.1 Global Budesonide and Formoterol Fumarate Sales by Region: 2021–2026
3.2.2 Global Budesonide and Formoterol Fumarate Sales by Region: 2027–2032
3.3 Global Budesonide and Formoterol Fumarate Revenue by Region: 2021–2032
3.3.1 Global Budesonide and Formoterol Fumarate Revenue by Region: 2021–2026
3.3.2 Global Budesonide and Formoterol Fumarate Revenue by Region: 2027–2032
3.4 North America Budesonide and Formoterol Fumarate Market Facts & Figures by Country
3.4.1 North America Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Budesonide and Formoterol Fumarate Sales by Country (2021–2032)
3.4.3 North America Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Budesonide and Formoterol Fumarate Market Facts & Figures by Country
3.5.1 Europe Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Budesonide and Formoterol Fumarate Sales by Country (2021–2032)
3.5.3 Europe Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide and Formoterol Fumarate Market Facts & Figures by Region
3.6.1 Asia Pacific Budesonide and Formoterol Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (2021–2032)
3.6.3 Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Budesonide and Formoterol Fumarate Market Facts & Figures by Country
3.7.1 Latin America Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Budesonide and Formoterol Fumarate Sales by Country (2021–2032)
3.7.3 Latin America Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Budesonide and Formoterol Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (2021–2032)
3.8.3 Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide and Formoterol Fumarate Sales by Type (2021–2032)
4.1.1 Global Budesonide and Formoterol Fumarate Sales by Type (2021–2026)
4.1.2 Global Budesonide and Formoterol Fumarate Sales by Type (2027–2032)
4.1.3 Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2021–2032)
4.2 Global Budesonide and Formoterol Fumarate Revenue by Type (2021–2032)
4.2.1 Global Budesonide and Formoterol Fumarate Revenue by Type (2021–2026)
4.2.2 Global Budesonide and Formoterol Fumarate Revenue by Type (2027–2032)
4.2.3 Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2021–2032)
4.3 Global Budesonide and Formoterol Fumarate Price by Type (2021–2032)
5 Segment by Application
5.1 Global Budesonide and Formoterol Fumarate Sales by Application (2021–2032)
5.1.1 Global Budesonide and Formoterol Fumarate Sales by Application (2021–2026)
5.1.2 Global Budesonide and Formoterol Fumarate Sales by Application (2027–2032)
5.1.3 Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2021–2032)
5.2 Global Budesonide and Formoterol Fumarate Revenue by Application (2021–2032)
5.2.1 Global Budesonide and Formoterol Fumarate Revenue by Application (2021–2026)
5.2.2 Global Budesonide and Formoterol Fumarate Revenue by Application (2027–2032)
5.2.3 Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2021–2032)
5.3 Global Budesonide and Formoterol Fumarate Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Budesonide and Formoterol Fumarate Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Company Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Viatris Budesonide and Formoterol Fumarate Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Budesonide and Formoterol Fumarate Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Budesonide and Formoterol Fumarate Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Chia Tai Tianqing Pharmaceutical
6.5.1 Chia Tai Tianqing Pharmaceutical Company Information
6.5.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.5.3 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Product Portfolio
6.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.6 Joincare Pharmaceutical Group Industry
6.6.1 Joincare Pharmaceutical Group Industry Company Information
6.6.2 Joincare Pharmaceutical Group Industry Description and Business Overview
6.6.3 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Product Portfolio
6.6.5 Joincare Pharmaceutical Group Industry Recent Developments/Updates
6.7 Lunan Pharmaceutical Group
6.7.1 Lunan Pharmaceutical Group Company Information
6.7.2 Lunan Pharmaceutical Group Description and Business Overview
6.7.3 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Product Portfolio
6.7.5 Lunan Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide and Formoterol Fumarate Industry Chain Analysis
7.2 Budesonide and Formoterol Fumarate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide and Formoterol Fumarate Production Mode & Process Analysis
7.4 Budesonide and Formoterol Fumarate Sales and Marketing
7.4.1 Budesonide and Formoterol Fumarate Sales Channels
7.4.2 Budesonide and Formoterol Fumarate Distributors
7.5 Budesonide and Formoterol Fumarate Customer Analysis
8 Budesonide and Formoterol Fumarate Market Dynamics
8.1 Budesonide and Formoterol Fumarate Industry Trends
8.2 Budesonide and Formoterol Fumarate Market Drivers
8.3 Budesonide and Formoterol Fumarate Market Challenges
8.4 Budesonide and Formoterol Fumarate Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Budesonide and Formoterol Fumarate Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Budesonide and Formoterol Fumarate Market Value by Dosage Form (US$ Million), 2025 vs 2032
Table 3. Global Budesonide and Formoterol Fumarate Market Value by Production Technology (US$ Million), 2025 vs 2032
Table 4. Global Budesonide and Formoterol Fumarate Market Value by Sales Channels (US$ Million), 2025 vs 2032
Table 5. Global Budesonide and Formoterol Fumarate Market Value by Application (US$ Million), 2025 vs 2032
Table 6. Global Budesonide and Formoterol Fumarate Market Competitive Situation by Manufacturers in 2025
Table 7. Global Budesonide and Formoterol Fumarate Sales (Units) of Key Manufacturers (2021–2026)
Table 8. Global Budesonide and Formoterol Fumarate Sales Market Share by Manufacturers (2021–2026)
Table 9. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Manufacturers (2021–2026)
Table 10. Global Budesonide and Formoterol Fumarate Revenue Share by Manufacturers (2021–2026)
Table 11. Global Market Budesonide and Formoterol Fumarate Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 12. Global Key Players of Budesonide and Formoterol Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
Table 13. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Manufacturing Sites and Headquarters
Table 14. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Product Types and Applications
Table 15. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Date of Entry into the Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Budesonide and Formoterol Fumarate Companies by Tier (Tier 1, Tier 2, Tier 3), based on Budesonide and Formoterol Fumarate Revenue, 2025
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Budesonide and Formoterol Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Budesonide and Formoterol Fumarate Sales by Region (Units), 2021–2026
Table 21. Global Budesonide and Formoterol Fumarate Sales Market Share by Region (2021–2026)
Table 22. Global Budesonide and Formoterol Fumarate Sales by Region (Units), 2027–2032
Table 23. Global Budesonide and Formoterol Fumarate Sales Market Share by Region (2027–2032)
Table 24. Global Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2021–2026
Table 25. Global Budesonide and Formoterol Fumarate Revenue Market Share by Region (2021–2026)
Table 26. Global Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2027–2032
Table 27. Global Budesonide and Formoterol Fumarate Revenue Market Share by Region (2027–2032)
Table 28. North America Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. North America Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026
Table 30. North America Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032
Table 31. North America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026
Table 32. North America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032
Table 33. Europe Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Europe Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026
Table 35. Europe Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032
Table 36. Europe Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026
Table 37. Europe Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032
Table 38. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (Units), 2021–2026
Table 40. Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (Units), 2027–2032
Table 41. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2021–2026
Table 42. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2027–2032
Table 43. Latin America Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Latin America Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026
Table 45. Latin America Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032
Table 46. Latin America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026
Table 47. Latin America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032
Table 48. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026
Table 50. Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032
Table 51. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026
Table 52. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032
Table 53. Global Budesonide and Formoterol Fumarate Sales (Units) by Type (2021–2026)
Table 54. Global Budesonide and Formoterol Fumarate Sales (Units) by Type (2027–2032)
Table 55. Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2021–2026)
Table 56. Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2027–2032)
Table 57. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Type (2021–2026)
Table 58. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Type (2027–2032)
Table 59. Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2021–2026)
Table 60. Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2027–2032)
Table 61. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2021–2026)
Table 62. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2027–2032)
Table 63. Global Budesonide and Formoterol Fumarate Sales (Units) by Application (2021–2026)
Table 64. Global Budesonide and Formoterol Fumarate Sales (Units) by Application (2027–2032)
Table 65. Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2021–2026)
Table 66. Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2027–2032)
Table 67. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Application (2021–2026)
Table 68. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Application (2027–2032)
Table 69. Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2021–2026)
Table 70. Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2027–2032)
Table 71. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2021–2026)
Table 72. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2027–2032)
Table 73. AstraZeneca Company Information
Table 74. AstraZeneca Description and Business Overview
Table 75. AstraZeneca Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 76. AstraZeneca Budesonide and Formoterol Fumarate Product
Table 77. AstraZeneca Recent Developments/Updates
Table 78. Viatris Company Information
Table 79. Viatris Description and Business Overview
Table 80. Viatris Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 81. Viatris Budesonide and Formoterol Fumarate Product
Table 82. Viatris Recent Developments/Updates
Table 83. Teva Company Information
Table 84. Teva Description and Business Overview
Table 85. Teva Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 86. Teva Budesonide and Formoterol Fumarate Product
Table 87. Teva Recent Developments/Updates
Table 88. Sandoz Company Information
Table 89. Sandoz Description and Business Overview
Table 90. Sandoz Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 91. Sandoz Budesonide and Formoterol Fumarate Product
Table 92. Sandoz Recent Developments/Updates
Table 93. Chia Tai Tianqing Pharmaceutical Company Information
Table 94. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 95. Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 96. Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Product
Table 97. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 98. Joincare Pharmaceutical Group Industry Company Information
Table 99. Joincare Pharmaceutical Group Industry Description and Business Overview
Table 100. Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 101. Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Product
Table 102. Joincare Pharmaceutical Group Industry Recent Developments/Updates
Table 103. Lunan Pharmaceutical Group Company Information
Table 104. Lunan Pharmaceutical Group Description and Business Overview
Table 105. Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 106. Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Product
Table 107. Lunan Pharmaceutical Group Recent Developments/Updates
Table 108. Key Raw Materials Lists
Table 109. Raw Materials Key Suppliers Lists
Table 110. Budesonide and Formoterol Fumarate Distributors List
Table 111. Budesonide and Formoterol Fumarate Customers List
Table 112. Budesonide and Formoterol Fumarate Market Trends
Table 113. Budesonide and Formoterol Fumarate Market Drivers
Table 114. Budesonide and Formoterol Fumarate Market Challenges
Table 115. Budesonide and Formoterol Fumarate Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Product Picture of Budesonide and Formoterol Fumarate
Figure 2. Global Budesonide and Formoterol Fumarate Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Budesonide and Formoterol Fumarate Market Share by Type: 2025 & 2032
Figure 4. 80/4.5 μg / inhalation Product Picture
Figure 5. 160/4.5 μg / inhalation Product Picture
Figure 6. Global Budesonide and Formoterol Fumarate Market Value by Dosage Form (US$ Million), 2021–2032
Figure 7. Global Budesonide and Formoterol Fumarate Market Share by Dosage Form: 2025 vs 2032
Figure 8. Inhalation Powder Product Picture
Figure 9. Inhalation Aerosol Product Picture
Figure 10. Global Budesonide and Formoterol Fumarate Market Value by Production Technology (US$ Million), 2021–2032
Figure 11. Global Budesonide and Formoterol Fumarate Market Share by Production Technology: 2025 vs 2032
Figure 12. Innovator Product Picture
Figure 13. Generic Product Picture
Figure 14. Global Budesonide and Formoterol Fumarate Market Value by Sales Channels (US$ Million), 2021–2032
Figure 15. Global Budesonide and Formoterol Fumarate Market Share by Sales Channels: 2025 vs 2032
Figure 16. Hospitals Product Picture
Figure 17. Retail Product Picture
Figure 18. Online Product Picture
Figure 19. Global Budesonide and Formoterol Fumarate Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Budesonide and Formoterol Fumarate Market Share by Application: 2025 & 2032
Figure 21. Asthma
Figure 22. Chronic Obstructive Pulmonary Disease
Figure 23. Airway Constriction Relief
Figure 24. Others
Figure 25. Global Budesonide and Formoterol Fumarate Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Budesonide and Formoterol Fumarate Market Size (US$ Million), 2021–2032
Figure 27. Global Budesonide and Formoterol Fumarate Sales (Units), 2021–2032
Figure 28. Global Budesonide and Formoterol Fumarate Average Price (US$/Unit), 2021–2032
Figure 29. Budesonide and Formoterol Fumarate Report Years Considered
Figure 30. Budesonide and Formoterol Fumarate Sales Share by Manufacturers in 2025
Figure 31. Global Budesonide and Formoterol Fumarate Revenue Share by Manufacturers in 2025
Figure 32. Top 5 and Top 10 Global Budesonide and Formoterol Fumarate Players: Market Share by Revenue in Budesonide and Formoterol Fumarate in 2025
Figure 33. Budesonide and Formoterol Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 34. Global Budesonide and Formoterol Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 35. North America Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)
Figure 36. North America Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)
Figure 37. United States Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Canada Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Europe Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)
Figure 40. Europe Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)
Figure 41. Germany Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. France Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. U.K. Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Italy Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Russia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Asia Pacific Budesonide and Formoterol Fumarate Sales Market Share by Region (2021–2032)
Figure 47. Asia Pacific Budesonide and Formoterol Fumarate Revenue Market Share by Region (2021–2032)
Figure 48. China Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Japan Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. South Korea Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. India Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Australia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. China Taiwan Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Southeast Asia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)
Figure 56. Latin America Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)
Figure 57. Mexico Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Colombia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Middle East and Africa Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)
Figure 62. Middle East and Africa Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)
Figure 63. Turkey Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Saudi Arabia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. UAE Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. Global Sales Market Share of Budesonide and Formoterol Fumarate by Type (2021–2032)
Figure 67. Global Revenue Market Share of Budesonide and Formoterol Fumarate by Type (2021–2032)
Figure 68. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2021–2032)
Figure 69. Global Sales Market Share of Budesonide and Formoterol Fumarate by Application (2021–2032)
Figure 70. Global Revenue Market Share of Budesonide and Formoterol Fumarate by Application (2021–2032)
Figure 71. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2021–2032)
Figure 72. Budesonide and Formoterol Fumarate Value Chain
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed